Modified CLL International Prognostic Index (CLL-LIPI) using lymphocyte doubling time (LDT) in place of IgHV mutation status in resource-limited settings predicts time to first treatment and overall survival.
Deepesh P LadV TejaswiNishant JindalPankaj MalhotraAlka KhadwalGaurav PrakashArihant JainSreejesh SreedharanunniManupdesh Singh SachdevaShano NaseemNeelam VarmaSubhash VarmaPublished in: Leukemia & lymphoma (2020)